Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Intranasal Inoculation of Mice with Yersinia pestis and Processing of Pulmonary Tissue for Analysis.

Pechous RD.

Methods Mol Biol. 2019;2010:17-28. doi: 10.1007/978-1-4939-9541-7_2.

PMID:
31177428
2.

Modeling Pneumonic Plague in Human Precision-Cut Lung Slices Highlights a Role for the Plasminogen Activator Protease in Facilitating Type 3 Secretion.

Banerjee SK, Huckuntod SD, Mills SD, Kurten RC, Pechous RD.

Infect Immun. 2019 Jul 23;87(8). pii: e00175-19. doi: 10.1128/IAI.00175-19. Print 2019 Aug.

3.

With Friends Like These: The Complex Role of Neutrophils in the Progression of Severe Pneumonia.

Pechous RD.

Front Cell Infect Microbiol. 2017 May 1;7:160. doi: 10.3389/fcimb.2017.00160. eCollection 2017. Review.

4.

Pneumonic Plague: The Darker Side of Yersinia pestis.

Pechous RD, Sivaraman V, Stasulli NM, Goldman WE.

Trends Microbiol. 2016 Mar;24(3):190-197. doi: 10.1016/j.tim.2015.11.008. Epub 2015 Dec 14. Review.

PMID:
26698952
5.

Spatially distinct neutrophil responses within the inflammatory lesions of pneumonic plague.

Stasulli NM, Eichelberger KR, Price PA, Pechous RD, Montgomery SA, Parker JS, Goldman WE.

MBio. 2015 Oct 13;6(5):e01530-15. doi: 10.1128/mBio.01530-15.

6.

Illuminating Targets of Bacterial Secretion.

Pechous RD, Goldman WE.

PLoS Pathog. 2015 Aug 6;11(8):e1004981. doi: 10.1371/journal.ppat.1004981. eCollection 2015 Aug. Review. No abstract available.

7.

Yersinia pestis activates both IL-1β and IL-1 receptor antagonist to modulate lung inflammation during pneumonic plague.

Sivaraman V, Pechous RD, Stasulli NM, Eichelberger KR, Miao EA, Goldman WE.

PLoS Pathog. 2015 Mar 17;11(3):e1004688. doi: 10.1371/journal.ppat.1004688. eCollection 2015 Mar. Erratum in: PLoS Pathog. 2015 May;11(5):e1004921.

8.

In vivo transcriptional profiling of Yersinia pestis reveals a novel bacterial mediator of pulmonary inflammation.

Pechous RD, Broberg CA, Stasulli NM, Miller VL, Goldman WE.

MBio. 2015 Feb 17;6(1):e02302-14. doi: 10.1128/mBio.02302-14.

9.

Early host cell targets of Yersinia pestis during primary pneumonic plague.

Pechous RD, Sivaraman V, Price PA, Stasulli NM, Goldman WE.

PLoS Pathog. 2013;9(10):e1003679. doi: 10.1371/journal.ppat.1003679. Epub 2013 Oct 3.

10.

Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development.

Pechous RD, McCarthy TR, Zahrt TC.

Microbiol Mol Biol Rev. 2009 Dec;73(4):684-711. doi: 10.1128/MMBR.00028-09. Review.

11.

A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge.

Pechous RD, McCarthy TR, Mohapatra NP, Soni S, Penoske RM, Salzman NH, Frank DW, Gunn JS, Zahrt TC.

PLoS One. 2008 Jun 25;3(6):e2487. doi: 10.1371/journal.pone.0002487.

12.

Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS.

Li J, Ryder C, Mandal M, Ahmed F, Azadi P, Snyder DS, Pechous RD, Zahrt T, Inzana TJ.

Microbiology. 2007 Sep;153(Pt 9):3141-53.

PMID:
17768257

Supplemental Content

Loading ...
Support Center